Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.
作者信息
Doshi B S, Kulkarni R D, Chauhan B L, Wilkinson G R
出版信息
Br J Clin Pharmacol. 1990 Nov;30(5):779-80. doi: 10.1111/j.1365-2125.1990.tb03850.x.
Abstract
摘要
相似文献
1
Frequency of impaired mephenytoin 4'-hydroxylation in an Indian population.印度人群中苯妥英4'-羟基化受损的频率。
Br J Clin Pharmacol. 1990 Nov;30(5):779-80. doi: 10.1111/j.1365-2125.1990.tb03850.x.
2
Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations.日本和白种人群肝脏中CYP2C9和2C19基因型与甲苯磺丁脲甲基羟化及S-美芬妥因4'-羟化活性之间的关系。
Pharmacogenetics. 1997 Apr;7(2):103-13. doi: 10.1097/00008571-199704000-00003.
3
Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial.印度尼西亚人群中氨苯砜N-乙酰化、美托洛尔α-羟基化和S-美芬妥英4-羟基化多态性：一项鸡尾酒和扩展表型评估试验。
Clin Pharmacol Ther. 1994 Aug;56(2):142-53. doi: 10.1038/clpt.1994.117.
4
Why are diazepam metabolism and polymorphic S-mephenytoin hydroxylation associated with each other in white and Korean populations but not in Chinese populations?为什么地西泮代谢和多态性S-美芬妥因羟化在白种人和韩国人群中相互关联，而在中国人群中却没有这种关联？
Clin Pharmacol Ther. 1993 May;53(5):608-10. doi: 10.1038/clpt.1993.77.
5
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians.美芬妥因p(4')-羟化作用的基因多态性：东方人与高加索人的差异。
Br J Clin Pharmacol. 1985 Apr;19(4):483-7. doi: 10.1111/j.1365-2125.1985.tb02673.x.
6
Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects.
Pharmacogenetics. 1992 Feb;2(1):25-31. doi: 10.1097/00008571-199202000-00005.
7
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.高加索人中美芬妥英羟化缺乏症：一种新的氧化药物代谢多态性的频率
Clin Pharmacol Ther. 1984 Dec;36(6):773-80. doi: 10.1038/clpt.1984.256.
8
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.韩国人群中S-美芬妥因羟化缺乏症的发生率及地西泮药代动力学的表型间差异。
Clin Pharmacol Ther. 1992 Aug;52(2):160-9. doi: 10.1038/clpt.1992.125.
9
Mephenytoin hydroxylation in the Cuna Amerindians of Panama.巴拿马库纳美洲印第安人中美芬妥英的羟基化作用
Br J Clin Pharmacol. 1988 Jan;25(1):75-9. doi: 10.1111/j.1365-2125.1988.tb03284.x.
10
Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.
Eur J Clin Pharmacol. 1993;44(6):593-5. doi: 10.1007/BF02440867.
引用本文的文献
1
Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.全球人群中CYP2C19等位基因、“预测”表型及“测量”代谢表型的种族间差异。
Pharmacogenomics J. 2016 Apr;16(2):113-23. doi: 10.1038/tpj.2015.70. Epub 2015 Oct 27.
2
Genetic variants in the cytochrome P450 2D6 gene in the Sri Lankan population.斯里兰卡人群细胞色素P450 2D6基因中的遗传变异。
Indian J Hum Genet. 2013 Oct;19(4):392-6. doi: 10.4103/0971-6866.124361.
3
Clinical significance of the cytochrome P450 2C19 genetic polymorphism.细胞色素P450 2C19基因多态性的临床意义
Clin Pharmacokinet. 2002;41(12):913-58. doi: 10.2165/00003088-200241120-00002.
4
Cytochrome P450 enzymes and drug metabolism--basic concepts and methods of assessment.细胞色素P450酶与药物代谢——评估的基本概念和方法
Cell Mol Neurobiol. 1999 Jun;19(3):309-23. doi: 10.1023/a:1006993631057.
5
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19.药物相互作用与细胞色素P450系统。细胞色素P450 2C19的作用。
Clin Pharmacokinet. 1995;29 Suppl 1:45-52. doi: 10.2165/00003088-199500291-00008.
6
Debrisoquine and mephenytoin oxidation in Sinhalese: a population study.僧伽罗人的去甲异喹胍和甲妥英氧化：一项群体研究。
Br J Clin Pharmacol. 1994 Nov;38(5):466-70. doi: 10.1111/j.1365-2125.1994.tb04384.x.
本文引用的文献
1
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.高加索人中美芬妥英羟化缺乏症：一种新的氧化药物代谢多态性的频率
Clin Pharmacol Ther. 1984 Dec;36(6):773-80. doi: 10.1038/clpt.1984.256.
2
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.日本人群与白种人群之间在异喹胍和甲妥英羟基化遗传多态性上的种族差异。
Clin Pharmacol Ther. 1985 Oct;38(4):402-8. doi: 10.1038/clpt.1985.194.
3
Mephenytoin hydroxylation in the Cuna Amerindians of Panama.巴拿马库纳美洲印第安人中美芬妥英的羟基化作用
Br J Clin Pharmacol. 1988 Jan;25(1):75-9. doi: 10.1111/j.1365-2125.1988.tb03284.x.
4
Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data.人类进化的重构：整合基因、考古和语言数据。
Proc Natl Acad Sci U S A. 1988 Aug;85(16):6002-6. doi: 10.1073/pnas.85.16.6002.
5
Low frequency of slow debrisoquine hydroxylation in a native Chinese population.中国本土人群中慢代谢异喹胍羟化反应的低发生率。
Lancet. 1987 Oct 10;2(8563):852-3. doi: 10.1016/s0140-6736(87)91034-8.
6
Effects of ketoconazole on the polymorphic 4-hydroxylations of S-mephenytoin and debrisoquine.酮康唑对S-美芬妥英和异喹胍多态性4-羟化反应的影响。
Br J Clin Pharmacol. 1989 Aug;28(2):161-5. doi: 10.1111/j.1365-2125.1989.tb05409.x.
7
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese.远东东方人群中美托洛尔和苯妥英氧化多态性：日本人与中国大陆人对比
Clin Pharmacol Ther. 1989 Aug;46(2):198-207. doi: 10.1038/clpt.1989.126.
8
Genetic polymorphism of S-mephenytoin hydroxylation.S-美芬妥因羟基化的基因多态性。
Pharmacol Ther. 1989;43(1):53-76. doi: 10.1016/0163-7258(89)90047-8.
9
Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin.
Br J Clin Pharmacol. 1990 Sep;30(3):471-5. doi: 10.1111/j.1365-2125.1990.tb03799.x.
10
The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects.异喹胍/鹰爪豆碱代谢的遗传多态性——临床方面
Pharmacol Ther. 1990;46(3):377-94. doi: 10.1016/0163-7258(90)90025-w.
Zotero 插件